CAS 287403-39-8

3-Thiomorpholinecarboxamide,4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-, (3S)-

Description:

3-Thiomorpholinecarboxamide, 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-, (3S)-, with CAS number 287403-39-8, is a chemical compound characterized by its complex structure that includes a thiomorpholine ring, a sulfonyl group, and a hydroxylamine moiety. This compound typically exhibits properties associated with both amides and sulfonamides, which may influence its solubility and reactivity. The presence of the butynyloxy group suggests potential for hydrophobic interactions, while the hydroxylamine functionality may impart unique reactivity, particularly in redox reactions. The stereochemistry indicated by (3S) suggests a specific spatial arrangement of atoms, which can significantly affect the compound's biological activity and interaction with other molecules. Such compounds are often investigated for their potential pharmaceutical applications, particularly in the development of therapeutic agents targeting specific biological pathways. Overall, the characteristics of this compound make it a subject of interest in medicinal chemistry and related fields.

Formula: C₁₇H₂₂N₂O₅S₂

(S)-4-((4-(But-2-yn-1-yloxy)phenyl)sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

CAS: 287403-39-8

Formula: C₁₇H₂₂N₂O₅S₂

Purity: 98%

Molecular weight: 398.4970

Ref: IN-DA01ENKN

TMI-1

CAS: 287403-39-8

TMI-1

Purity: ≥95%

Molecular weight: 398.5g/mol

Ref: 54-BUP03835

TMI-1

CAS: 287403-39-8

TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.

Formula: C₁₇H₂₂N₂O₅S₂

Purity: 97.36%

Color and Shape: Solid

Molecular weight: 398.5

Ref: TM-T28985

TMI-1

CAS: 287403-39-8

TMI-1 is a human serum albumin that has been chemically modified to contain an ester linkage. The modification of the protein structure improves its stability and reduces the risk of immunogenicity. TMI-1 has been shown to have antitumor effects in mice, reducing tumor growth by up to 80%. It also has a therapeutic effect on inflammatory skin diseases, such as atopic dermatitis, psoriasis, and rosacea. TMI-1 can be used as a diagnostic agent or as a biocompatible polymer for drug delivery.

Formula: C₁₇H₂₂N₂O₅S₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 398.5 g/mol

Ref: 3D-MLA40339